Dbv Technologies SA
DBVT12.900USD
+0.650+5.31%
收盘 10/03, 16:00（美东）报价延迟15分钟
1.76B总市值
亏损市盈率 TTM
关于 Dbv Technologies SA 公司
DBV Technologies SA 是一家总部位于法国的临床阶段生物制药公司，致力于通过开发名为 Vaskin 的技术平台改变免疫疗法领域。该公司的治疗方法基于表皮免疫疗法 (EPIT)，这是其专有方法，使用 Viaskin 通过完整的皮肤将生物活性化合物输送到免疫系统。该公司致力于将其技术用于治疗患有严重食物过敏的患者（包括婴儿和儿童），对他们来说，安全至关重要，因为有害过敏原进入他们的血液会引起严重或危及生命的过敏反应，例如过敏性休克。该公司的过敏治疗产品组合包括 Viaskin Peanut、Viaskin Milk 和 Viaskin Egg。该公司在美国经营一家子公司 DBV Technologies Inc.。
Dbv Technologies SA简介
公司代码DBVT
公司名称Dbv Technologies SA
上市日期Mar 29, 2012
CEOMr. Daniel Tasse
员工数量108
证券类型Depository Receipt
年结日Mar 29
公司地址Batiment IRO
城市CHATILLON
上市交易所NASDAQ Capital Market Consolidated
国家France
邮编92320
电话33155427878
网址https://www.dbv-technologies.com/
公司代码DBVT
上市日期Mar 29, 2012
CEOMr. Daniel Tasse
Dbv Technologies SA公司高管
名称
名称/职务
职务
持股
持股变动
Mr. James Briggs
Mr. James Briggs
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Ms. Mailys Ferrere
Ms. Mailys Ferrere
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Michael J. Goller
Mr. Michael J. Goller
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Ravi M. Rao, Ph.D.
Dr. Ravi M. Rao, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Pharis Mohideen, M.D.
Dr. Pharis Mohideen, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Virginie Boucinha
Ms. Virginie Boucinha
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Daniel Tasse
Mr. Daniel Tasse
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Daniele Guyot-Caparros
Ms. Daniele Guyot-Caparros
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Julie O'Neill
Ms. Julie O'Neill
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Katie Matthews
Ms. Katie Matthews
Investor Relations
Investor Relations
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. James Briggs
Mr. James Briggs
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Ms. Mailys Ferrere
Ms. Mailys Ferrere
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Michael J. Goller
Mr. Michael J. Goller
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Ravi M. Rao, Ph.D.
Dr. Ravi M. Rao, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Pharis Mohideen, M.D.
Dr. Pharis Mohideen, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Virginie Boucinha
Ms. Virginie Boucinha
Chief Financial Officer
Chief Financial Officer
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 10月3日 周五
更新时间: 10月3日 周五
持股股东
股东类型
持股股东
持股股东
占比
Baker Bros. Advisors LP
1.07%
Vivo Capital, LLC
0.77%
Adage Capital Management, L.P.
0.77%
MPM BioImpact LLC
0.77%
Octagon Capital Advisors LP
0.74%
其他
95.87%
持股股东
持股股东
占比
Baker Bros. Advisors LP
1.07%
Vivo Capital, LLC
0.77%
Adage Capital Management, L.P.
0.77%
MPM BioImpact LLC
0.77%
Octagon Capital Advisors LP
0.74%
其他
95.87%
股东类型
持股股东
占比
Hedge Fund
3.09%
Investment Advisor/Hedge Fund
0.78%
Venture Capital
0.77%
Investment Advisor
0.64%
Research Firm
0.01%
其他
94.70%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
75
7.25M
5.30%
+3.45M
2025Q2
67
2.48M
1.81%
-1.70M
2025Q1
68
2.48M
1.81%
-1.72M
2024Q4
69
2.75M
14.25%
-1.75M
2024Q3
71
3.24M
16.85%
-1.47M
2024Q2
79
3.44M
17.88%
-1.57M
2024Q1
79
3.80M
19.76%
-1.19M
2023Q4
86
3.80M
19.69%
-1.09M
2023Q3
94
4.46M
23.21%
-1.44M
2023Q2
90
4.62M
24.57%
-904.51K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Baker Bros. Advisors LP
1.46M
1.07%
--
--
Jun 30, 2025
Vivo Capital, LLC
1.05M
0.77%
+1.05M
--
Jun 30, 2025
Adage Capital Management, L.P.
1.05M
0.77%
+1.05M
--
Jun 30, 2025
MPM BioImpact LLC
1.05M
0.77%
+1.05M
--
Jun 30, 2025
Octagon Capital Advisors LP
1.02M
0.74%
+1.02M
--
Jun 30, 2025
Yiheng Capital Management, L.P.
656.31K
0.48%
--
--
Jun 30, 2025
Great Point Partners, LLC
374.68K
0.27%
+374.68K
--
Jun 30, 2025
Millennium Management LLC
268.01K
0.2%
+268.01K
--
Jun 30, 2025
UBS Financial Services, Inc.
164.20K
0.12%
+713.00
+0.44%
Jun 30, 2025
Nan Fung Trinity (HK) Limited
37.09K
0.03%
+37.09K
--
Jun 30, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Nov 13, 2024
Merger
5→1
Nov 13, 2024
Merger
5→1
Nov 13, 2024
Merger
5→1
Nov 13, 2024
Merger
5→1
May 17, 2024
Merger
2→1
May 17, 2024
Merger
2→1
公告日期
类型
比率
Nov 13, 2024
Merger
5→1
Nov 13, 2024
Merger
5→1
Nov 13, 2024
Merger
5→1
Nov 13, 2024
Merger
5→1
May 17, 2024
Merger
2→1
May 17, 2024
Merger
2→1
May 17, 2024
Merger
2→1
May 17, 2024
Merger
2→1
